| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | paricalcitol | FAERS: 4 | OFFSIDES US FAERS | |
| 2 | Cinacalcet | FAERS: 2 | US FAERS | |
| 3 | Celecoxib | FAERS: 1 | US FAERS | |
| 4 | Lenalidomide | FAERS: 1 | US FAERS | |
| 5 | Rifaximin | FAERS: 1 | US FAERS | |
| 6 | Rivaroxaban | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 7 | lenvatinib | FAERS: 1 | US FAERS | |
| 8 | Cinacalcet | OFFSIDES | ||
| 9 | Flurazepam | OFFSIDES | ||
| 10 | Lanthanum carbonate hydrate | OFFSIDES | ||
| 11 | Methocarbamol | OFFSIDES | ||
| 12 | Phenprocoumon | OFFSIDES | ||
| 13 | Phosphorus | OFFSIDES | ||
| 14 | Piperacillin | OFFSIDES | ||
| 15 | Primidone | OFFSIDES | ||
| 16 | Sevelamer | OFFSIDES | ||
| 17 | Sodium ferric gluconate complex | OFFSIDES | ||
| 18 | Torsemide | SIDER | ||
| 19 | alfacalcidol | OFFSIDES | ||
| 20 | calcium acetate | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.